Marlene Wewalka
Overview
Explore the profile of Marlene Wewalka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wewalka M, Schneeweiss M, Haselwanter P, Schneeweiss B, Zauner C
Nutrition
. 2022 Jun;
101:111684.
PMID: 35660504
Objectives: Resting energy expenditure (REE) declines with age in healthy individuals, independent of the age-related decrease in lean body mass. The aim of this study was to evaluate whether this...
2.
Simbrunner B, Beer A, Woran K, Schmitz F, Primas C, Wewalka M, et al.
Wien Klin Wochenschr
. 2020 Jan;
132(1-2):1-11.
PMID: 31912289
Background And Aims: Portal hypertensive gastropathy (PHG) is common in patients with cirrhosis and may cause bleeding. This study systematically explored the independent impact of patient characteristics, portal hypertension and...
3.
Steiner E, Breuer R, Kazianka L, Wewalka M, Stimpfl T, Reiter B, et al.
Pancreas
. 2019 Jul;
48(7):953-957.
PMID: 31268979
Objectives: New-onset diabetes frequently resolves after pancreaticoduodenectomy (PD). Glucagon-like peptide-1 (GLP-1) conceivably is involved as its release is enhanced by rapid gastric emptying and distal bowel exposure to nutrients. We...
4.
Schneeweiss M, Wewalka M, Zauner C
N Engl J Med
. 2019 Feb;
380(5):498.
PMID: 30702242
No abstract available.
5.
Wewalka M, Drolz A, Seeland B, Schneeweiss M, Schmid M, Schneeweiss B, et al.
Eur J Clin Nutr
. 2018 Aug;
73(1):158.
PMID: 30082845
After publication, the author noticed that Table 2 was incorrectly formatted for the final PDF despite being correct in earlier proofs. The table was correct in the HTML version of...
6.
Wewalka M, Pablik E, Zauner C
Eur J Clin Nutr
. 2018 Jul;
73(1):150-151.
PMID: 30018460
No abstract available.
7.
Wewalka M, Drolz A, Seeland B, Schneeweiss M, Schmid M, Schneeweiss B, et al.
Eur J Clin Nutr
. 2018 Feb;
72(4):496-503.
PMID: 29459791
Background/objectives: Hyperglycemia is common in critically ill patients and associated with increased mortality. It has been suggested that different nutrition formulas may beneficially influence glucose levels in surgical intensive care...
8.
Panosian J, Ding S, Wewalka M, Simonson D, Goebel-Fabbri A, Foster K, et al.
Am J Med
. 2016 Aug;
130(1):83-92.
PMID: 27555097
Background: The purpose of this study was to compare effects of Roux-en-Y gastric bypass versus a multidisciplinary, group-based medical diabetes and weight management program on physical fitness and behaviors. Methods:...
9.
DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections
Neziri D, Pajenda S, Amuge R, Ilhan A, Wewalka M, Hormann G, et al.
J Nephropathol
. 2016 May;
5(2):65-71.
PMID: 27152292
Background: Acute kidney injury (AKI) is a life threatening condition. Despite intensive care treatment the occurrence cannot be predicted as very little indicators exist for direct measurement when tubular epithelial...
10.
Yu E, Wewalka M, Ding S, Simonson D, Foster K, Holst J, et al.
J Clin Endocrinol Metab
. 2015 Nov;
101(2):714-22.
PMID: 26600045
Context: Roux-en-Y gastric bypass (RYGB) leads to high-turnover bone loss, but little is known about skeletal effects of laparoscopic adjustable gastric banding (LAGB) or mechanisms underlying bone loss after bariatric...